Printer Friendly
The Free Library
21,435,892 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Browse Biotechnology industries topic

Licensing agreements subtopic

 

Articles

1-300 out of 568 article(s) nextnext page
Title Author Type Date Words
Unigene and Nordic Bioscience Enter Equity Transfer and Exclusive License Agreement for Proprietary Metabolic Peptide Analogs. May 9, 2013 1277
Alnylam and Tekmira Restructure Relationship and Settle All Litigation. Nov 13, 2012 1728
LabCorp Enters Into License Agreement with Sequella for use of B-SMART[TM] Technology to develop Rapid Tuberculosis Antimicrobial Susceptibility Test. Oct 22, 2012 533
Canada : Abattis signs LOI to purchase Bio-Pharma license and equipment from Vertical Design Systems Ltd. Oct 19, 2012 240
Japan : Astellas Enters License Agreement with Janssen to Develop and Commercialize ASP015K, an Astellas' Oral JAK Inhibitor for Immunologic Diseases. Oct 3, 2012 309
Islet Sciences Announces Exclusive License Agreement with the University of California (UCLA) to Commercialize Small Molecules for Islet Expansion. Sep 12, 2012 417
PDS Biotechnology Corporation Signs Worldwide Licensing Agreement with Merck KGaA for Versamune(TM). Jul 9, 2012 421
PDS Biotechnology Corporation Signs Worldwide Licensing Agreement with Merck KGaA for Versamune(TM). Jul 9, 2012 427
Retinalyze, LLC Signs Licensing Agreement for Vision Plan Reimbursement. Jun 20, 2012 991
GE Healthcare Licenses Genomic Biomarker for Lung Cancer from Insight Genetics. May 31, 2012 1095
Alnylam and PBL Sign License Agreement for Baulcombe & Hamilton RNAi Patent. May 23, 2012 1456
Late-Stage Drugs Are Hotbed for Co-Development and Licensing Deals. May 14, 2012 426
Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell Destruction and Diabetes Diagnostic. May 7, 2012 531
Dyadic International Expands License Agreement With Abengoa. May 1, 2012 629
IntelliCell BioSciences Signs Technology Licensing Agreement with Stem Cells 21 Thailand. Apr 10, 2012 638
Apexigen and Shanghai Duyiwei Biotechnology Co. Ltd Sign a License and Collaboration Agreement to Develop and Commercialize APX004. Mar 6, 2012 765
Roche and Life Technologies Corporation Sign New PCR IVD Licenses. Feb 22, 2012 460
NeoGenomics Enters Into Exclusive Worldwide Licensing Agreement With Health Discovery Corporation. Jan 9, 2012 930
Health Discovery Corporation Enters into Worldwide Licensing Agreement with NeoGenomics. Jan 9, 2012 968
Alnylam and Arrowhead Form Collaboration and Licensing Agreement. Jan 5, 2012 1892
Janssen Biotech, Inc. Announces Collaborative Development and Worldwide License Agreement for Investigational Anti-Cancer Drug, PCI-32765. Dec 8, 2011 727
Affymetrix Completes Strategic Licensing Agreement with Genisphere for Proprietary MicroRNA Reagents. Nov 17, 2011 791
Daiichi Sankyo To License ARQ 092 from ArQule, the First New Compound Resulting from the Companies' Joint AKIP Research Collaboration. Nov 10, 2011 1128
Blaze Bioscience Licenses Tumor Paint Technology from Fred Hutchinson Cancer Research Center. Oct 18, 2011 446
Pfizer Announces Licensing Agreement With Puma Biotechnology, Inc. For The Development And Commercialization Of Neratinib, An Investigational Pan-HER Inhibitor. Oct 5, 2011 827
Sequenom signs European Licensing Pact With LifeCodexx. Aug 30, 2011 539
Kibow Biotech, Inc. Secures $2.4 Million Towards Its Human Clinical Trials by Continued Veterinary Licensing Agreement. Aug 24, 2011 496
TriLink BioTechnologies, Inc. Announces License Agreement with Lucigen Corporation. Jul 28, 2011 584
CSL Limited Signs Commercial License Agreement with Selexis SA. Jul 26, 2011 503
Cannabis Science Signs A New Non-Exclusive Commercial License Agreement with Rockbrook To Continue Its Strategic Partnership In The State Of Colorado. Jul 12, 2011 480
Dyadic International Enters Into Research and License Agreement With Major Player in the Animal Feed Industry. Jun 27, 2011 697
Generex Announces Intention to Dividend a Portion of Anticipated Amarantus BioSciences Shares to Its Shareholders upon a Reverse Stock Split. Jun 1, 2011 1444
AVEO Pharmaceuticals Enters into Worldwide License Agreement with Centocor Ortho Biotech to Develop and Commercialize RON-Targeted Antibodies. May 31, 2011 1063
Avjet Biotech Signs License Agreement with NC State to Commercialize Aviation Biofuel Technologies. Apr 21, 2011 489
Biotechnology company Xoma Ltd (Berkeley CA) said it signed a development and licensing deal with Les Laboratoires Servier (Neuilly-sur-Seine FRA) potentially worth more than $500 million for an anti-inflammatory drug candidate. Jan 10, 2011 200
Idaho Technology and Bio-Rad Sign License Agreement. Dec 21, 2010 205
Metamark and HistoRx Announce Licensing Agreement for AQUA Technology. Dec 20, 2010 603
Epigenomics and Predictive Biosciences Extend Licensing Deal for Prostate Cancer Test. Nov 16, 2010 814
Life Technologies Signs Exclusive License Agreement for DNA Error-Correction Technology from Novici Biotech LLC. Oct 11, 2010 864
Research and Markets: Royalty Rates in Biotech: a BVR's Guide to Full-Text Licensing Agreements. Oct 6, 2010 257
SP Scientific Signs License Agreement for Praxair's ControLyo[TM] Nucleation Technology. Sep 29, 2010 480
Clinical Genomics Pty Ltd and The Garvan Institute of Medical Research Enter into Licensing Agreement. Sep 27, 2010 577
Clinical Genomics Pty Ltd and The Garvan Institute of Medical Research Enter into Licensing Agreement. Sep 27, 2010 646
BVR Announces New Reference Guides for Licensing and Intellectual Property. Sep 23, 2010 478
TriLink BioTechnologies, Inc. Announces License Agreement with Biofortuna Ltd. Sep 14, 2010 801
Asklepios BioPharmaceutical Enters Into A Patent License Agreement With Pfizer. Sep 13, 2010 284
Pharma-Biotech Licensing Deals -- Stopgap Option or Way of the Future? -- Frost & Sullivan Web Conference. Conference news Aug 26, 2010 476
Pharma-Biotech Licensing Deals -- Stopgap Option or Way of the Future? -- Frost & Sullivan Web Conference. Conference news Aug 26, 2010 632
Research and Markets: Pharmaceutical Licensing Overview - Includes Assessment of Drug Discovery & Technology Deals Made by the Top 10 Pharma Companies. Aug 11, 2010 489
Idaho Technology Issues License to DuPont Qualicon. Jul 30, 2010 259
NovImmune Enters Exclusive Antibody Licensing Agreement with Genentech. Jul 26, 2010 459
OvaGene Oncology Licenses Gene-Based Technologies to Develop Novel Endometrial and Cervical Cancer Assays. Jul 12, 2010 921
MRC Technology Enters Into an Exclusive License Agreement With Genentech. Jul 11, 2010 768
MRC Technology Enters Into an Exclusive License Agreement With Genentech. Jul 11, 2010 773
Western States Biopharmaceuticals and University of Colorado Announce Exclusive Licensing Agreement for TCISM(TM) Targets to Treat Autoimmune Diseases. Jul 8, 2010 740
MorphoSys and Xencor Sign License and Collaboration Agreement for Clinical Antibody Program. Jun 28, 2010 1041
LILLY (ELI) & COMPANY - Marcadia - Lilly Novel Glucagon Program. Jun 28, 2010 583
International Stem Cell Corporation (ISCO.OB) Announces New Patent Issuance Under License Agreement. Jun 24, 2010 542
ImmunoCellular Therapeutics Announces Licensing Agreement with Targepeutics for Worldwide Intellectual Property Rights to Validated Immunotherapy Target. Jun 22, 2010 692
Advaxis and the University of Pennsylvania Reach Agreement. May 18, 2010 460
'Less is more' with the innovation of Avemar Fermented Wheat Germ Extract. May 1, 2010 536
Bicycle Therapeutics Signs License Agreement with EPFL and Adds SR One and SVLS to Seed Syndicate. Apr 29, 2010 727
Astra paying over $2 billion for Rigel arthritis drug. AstraZeneca Plc. Feb 22, 2010 394
Trillium and Biogen Idec Enter Into Global License Agreement. Jan 12, 2010 506
Syntiron LLC Enters Collaborative Development and Licensing Agreement with sanofi pasteur to Develop Its Prophylactic Vaccine against Staphylococcus aureus. Dec 16, 2009 573
Idaho Technology Issues License to Kapa Biosystems, Inc. Company overview Dec 15, 2009 300
EraGen Announces a Strategic Partnership, Licensing Agreement with Illumina. Nov 18, 2009 378
Dow AgroSciences, Chromatin Announce Research, License Agreements. Nov 11, 2009 559
Ligand Updates License Agreement with Exelixis. Nov 2, 2009 537
Celera Licenses Lung Cancer Intellectual Property from Medical Therapies. Oct 29, 2009 943
ThromboGenics is Shortlisted for "Biotech Company of the Year" and "Licensing Deal of the Year" at Scrip Awards 2009. Sep 11, 2009 789
Scarab Genomics and NeoClone Have Entered Into License Agreement for Antibodies Against Shiga Toxin. Sep 10, 2009 167
DEBIOPHARM/MERCURY SIGN LICENSE AGREEMENT FOR DEBIO 0930. Sep 1, 2009 626
Nutra Pharma Announces Licensing Agreement with XenaCare Holdings to Market and Distribute Cobroxin, a Treatment for Chronic Pain. Aug 26, 2009 699
Biosystems International Establishes Licensing Agreement with Lohocla Research Institute to Search for Novel Alcoholism Liver Disease Biomarkers. Jun 11, 2009 441
Exelixis and Sanofi-aventis Sign Global License Agreement for XL147 & XL765 and Launch Broad Collaboration for Discovery of PI3K Inhibitors. May 28, 2009 1121
Gene Bridges Licenses Recombineering Technology to Chugai Pharmaceutical Co., Ltd. May 26, 2009 485
Dyadic International and Abengoa Bioenergy New Technologies Settle Litigation and Enter into License Agreement for the Production of Cellulosic Ethanol. May 13, 2009 493
Idaho Technology Issues License to Finnzymes. May 12, 2009 297
Biovail Enters into Collaboration and License Agreement with Acadia for Pimavanserin. May 4, 2009 1032
ITI achieves major milestone with first license. Brief article May 1, 2009 267
Celera Licenses Cardiovascular Biomarkers and Other Intellectual Property from Perlegen. Apr 23, 2009 922
Genzyme Corp. Brief article Apr 6, 2009 233
Idaho Technology Issues License to Thermo Fisher Scientific. Mar 31, 2009 235
PDS Biotechnology Corporation Finalizes Commercial Licensing Agreement with Merck Eprova AG to Utilize Merck Eprova's Enantiomers of DOTAP Chloride in Immunotherapies. Feb 24, 2009 404
Transgenomic and Power3 Medical Complete Agreement for Exclusive License of Neurodegenerative Biomarker Test. Feb 1, 2009 761
Merck KGAA. Brief article Jan 19, 2009 154
ProFibrix Steps up Recombinant Fibrinogen Program With PER.C6(R) License From Crucell. Jan 13, 2009 479
Celsion Corporation to Hold Conference Call to Discuss Its Announced Japan License Agreement for Thermodox[R] with Yakult Honsha. Dec 16, 2008 795
Pressure BioSciences and Battelle Sign Exclusive Protein Analysis Patent License Agreement. Dec 1, 2008 692
Sequenom Announces Exclusive Licensing Agreement with Xenomics for Noninvasive Prenatal Diagnostics Using Transrenal DNA. Oct 30, 2008 937
Xenomics Announces License Agreement with Sequenom for Prenatal Diagnostic Applications of Transrenal Nucleic Acid Technology. Oct 30, 2008 567
Nanogen Extends Celera License Agreement for Additional IVD Products. Oct 23, 2008 384
Moraga Announces Licensing Agreement with Pharmacells, Ltd. Oct 8, 2008 269
Kuros and Aeris Announce Exclusive License Agreement in the Field of Lung Volume Reduction. Sep 23, 2008 651
Sequenom Announces Exclusive Licensing Agreement with Genomic Nanosystems for Digital PCR Technologies and Methods Patents. Sep 22, 2008 1138
Can-Fite Signs MOU With the Korean Company Kwang Dong Pharmaceutical for Licensing CF101 Rights for Korea. Sep 9, 2008 431
Neurologix Licenses Exclusive Rights to Key Gene from Aegera Therapeutics for Use as a Potential Gene Therapy for Huntington's Disease. Sep 3, 2008 1372
Smart Personalized Medicine, LLC, Founded by Dr. Richard Caruso, Signs Agreement with Health Discovery Corporation to Work to Develop New Breast Cancer Prognostic Test. Aug 29, 2008 498
GPC Biotech Reports that Celgene to Terminate Co-Development and License Agreement for Satraplatin. Aug 6, 2008 392
Invitrogen and WARF Sign License Agreement for Human Embryonic Stem Cells. May 8, 2008 615
Roche Diagnostics Licenses the Technology Used for the LightCycler(R) System to BIOTECON. Apr 29, 2008 506
Codon Devices and Merrimack Pharmaceuticals Enter Into Research, Development and License Agreement. Apr 16, 2008 482
Roche NimbleGen and Affymetrix Expand Licensing Agreement. Company overview Mar 13, 2008 383
BioWa Announces Expansion of License Agreement with Genentech for BioWa's POTELLIGENT(R) Technology. Mar 3, 2008 394
Advanced Cell Technology, Inc. Enters into License Agreement with Pharming Group N.V. Feb 29, 2008 612
Nara Biosciences Inc. Completes Exclusive Licensing Agreement with Boston University for Metabolic and Muscle Wasting Disorder Therapies Discovered in the MyoMouse. Feb 6, 2008 347
Nara Biosciences Inc. Inks License Agreement for MyoMouse Platform. Feb 6, 2008 311
ArQule Receives Payment for Initiation of ARQ 197 Trial in Japan. Feb 6, 2008 366
Invitrogen Enters Non-Coding RNA Licensing Agreement with IMBcom. Jan 17, 2008 758
Callisto Pharmaceuticals Amends and Restates Atiprimod License Agreement with Genzyme. Jan 7, 2008 938
Bard to License Hernia Product and Technology from Genzyme Corporation. Dec 17, 2007 449
Dyax and MorphoSys Sign License Agreement on Antibody-Related Patents. Nov 20, 2007 1037
GPC Biotech Announces Favorable Ruling in Arbitration with Spectrum Pharmaceuticals. Nov 6, 2007 732
Rosetta selects PCR as platform for its microRNA-based diagnostics to be launched in 2008. Nov 1, 2007 418
Amicus and Shire enter Into $440 million ex-US licensing agreement to develop and commercialize lysosomal storage disorder technology. Oct 1, 2007 965
Clinical Data Announces License Agreement With Victorian Clinical Genetics Services Ltd. Oct 1, 2007 948
RXi Pharmaceuticals Licenses RNA Chemistry Technologies from TriLink Biotechnologies. Sep 10, 2007 757
Affymetrix and Empire Genomics Enter Into Licensing Agreement. Sep 7, 2007 656
Abraxis BioScience Announces Licensing Agreement with Biocon Limited for the Commercialization of ABRAXANE in India. Aug 9, 2007 552
Proteo, Inc./Proteo Biotech AG - Minapharm/Rhein Minapharm Biogenetics SAE: Proteo Biotech, Germany and Minapharm, Egypt enter into development and license agreement for Elafin. Aug 9, 2007 887
Abraxis BioScience and Biocon Limited Announce Licensing Agreement for G-CSF in North America and the European Union. Jul 19, 2007 768
Clarient and Health Discovery initiate alliance with licensing agreement for new molecular diagnostic test for prostate cancer. Company overview Jul 1, 2007 809
ARQULE/KYOWA HAKKO KOGYO SIGN ARQ 197 ASIA LICENSE. Jun 1, 2007 654
Advanced Cell Technology and Wisconsin Alumni Research Foundation Announce Commercial License Agreement. May 2, 2007 655
Martek signs license and supply agreement. Brief article May 1, 2007 118
Arcadia Biosciences And SESVanderHave Seeds Enter Research and Commercial License Agreement for Development of Nitrogen Use Efficient Sugar Beets. Apr 26, 2007 503
Thrombogenics Announces License Agreement With Millipore for Commercialization of Stem Cell Medium Technology. Apr 16, 2007 873
Affitech Signs License Agreement for Single-Chain Antibody Technology with Micromet. Mar 28, 2007 392
Pluristem Life Systems, Inc. Announces First Licensing Agreement and Stock Swap With Stem Cell Innovations, Inc. Feb 22, 2007 1226
Valeant Pharmaceuticals & Metabasis Therapeutics Close Licensing Deal with Schering-Plough Corporation. Jan 11, 2007 220
Genentech and Seattle Genetics Announce Exclusive Global Licensing Agreement for Development and Commercialization of SGN-40. Jan 8, 2007 1075
IGI and Novavax enter into license agreement. Jan 5, 2007 446
Spectrum Pharmaceuticals Files Arbitration Claim Against GPC Biotech AG for Violations of Satraplatin License Agreement. Dec 14, 2006 819
Sangamo BioSciences and City of Hope Announce License Agreement and Research Collaboration to Develop Treatment for Brain Cancer. Dec 12, 2006 1623
Health Discovery Corporation Announces Worldwide License Agreement with Pfizer. Dec 11, 2006 364
ThromboGenics Announces License Agreement With Bharat Biotech for Novel Thrombolytic Agent. Dec 7, 2006 1109
ThromboGenics Announces License Agreement With Bharat Biotech for Novel Thrombolytic Agent. Dec 7, 2006 1107
Affymetrix and Baylor College of Medicine Enter into Licensing Agreement. Dec 5, 2006 651
Martek, mission Pharmacal sign supply agreement. Brief article Dec 1, 2006 99
Schering-Plough licenses worldwide rights to pradefovir, oral hepatitis B treatment in development with Valeant and Metabasis. Dec 1, 2006 524
Archemix Grants Ribomic a License to its Intellectual Property to Develop and Commercialize Aptamer-Based Reagents. Nov 29, 2006 568
RaySearch Laboratories: Nucletron and RaySearch Have Entered into a Development and License Agreement Regarding Treatment Planning for Proton Therapy in Cancer Treatment. Nov 16, 2006 677
Memry Corporation Announces Worldwide Licensing Agreement for Nitinol Stent Coatings. Nov 7, 2006 737
Martek, WhiteWave sign agreement. Brief article Nov 1, 2006 127
Caprion Pharmaceuticals Enters Into Oncology Target Licensing Agreement with Centocor Research and Development, Inc. Oct 11, 2006 269
Affymetrix and NimbleGen Systems Enter into Licensing Agreement. Oct 6, 2006 711
Asklepios Biopharmaceutical, Inc. Announces Cross License with GlaxoSmithKline. Sep 28, 2006 460
Health Discovery Corporation Announces Worldwide Licensing Agreement with Epigenomics AG. Sep 19, 2006 535
Lux Biosciences gains exclusive worldwide license for ophthalmic polyarylate patent estate from Rutgers. Sep 1, 2006 858
Neurologix Signs Strategic License Agreement for Component of Its Parkinson's Gene Therapy Product. Aug 7, 2006 1078
Health Discovery Announces Non-Exclusive Worldwide Licensing Agreement with Bruker Daltonics. Aug 1, 2006 785
Ryogen licenses human aminopeptidase P gene patent to OriGene. Aug 1, 2006 360
Pharsight Signs Sixth DMX(R) License Agreement. Jul 10, 2006 620
Celera Genomics and Specialty Laboratories Announce Licensing Agreement for Commercialization of Cirrhosis Testing; Genetic Testing Could Be a Better Predictor for High Risk HCV Infected Individuals Than Current Clinical Factors. Jun 22, 2006 1602
Affymetrix and Invitrogen Enter Into Licensing Agreement. Jun 21, 2006 625
Advanced BioNutrition Corp. Brief article Jun 1, 2006 115
BioActives Corporation. Brief article Jun 1, 2006 107
Lux Biosciences Raises $36 Million in Series A Financing and Signs Agreement for Advanced Clinical Stage Product. May 25, 2006 800
Dyax Corp. and ICOS Corporation Enter Into License Agreement for Discovery of Therapeutic Antibodies. May 22, 2006 696
Surge in Strategic Alliances and Licensing Deals to Boost Productivity of Pharmaceutical Companies. May 10, 2006 960
Ciba Specialty Chemicals forms JV with Biosignal. Brief article May 1, 2006 99
Ingenuity Systems Expands Scope of Licensing Agreement with Daiichi Pharmaceutical Co., Ltd. Apr 25, 2006 314
Signature Genomic Laboratories, LLC(R) and Affymetrix, Inc. Sign License Agreement. Feb 14, 2006 614
Fisher Biosciences unit, Cellomics, and Evotec Technologies Sign License Agreement; Companies to Collaborate on Cell-Biology Solutions for Life-Science Markets. Jan 30, 2006 609
MethylGene and Pharmion Announce North America, E.U. and International Licensing Agreement for Oncology Oral HDAC Inhibitors, Including MGCD0103. Jan 30, 2006 2021
Pharmion and MethylGene Announce North America, E.U. and International Licensing Agreement for Oncology Oral HDAC Inhibitors, Including MGCD0103. Jan 30, 2006 2095
Caprion Pharmaceuticals Enters Into Oncology Target Licensing Agreement with ImClone Systems. Jan 10, 2006 319
Commonwealth Biotechnologies, Inc. and Prism Pharmaceuticals, Inc. Enter into License Agreement to Develop Helix-Based Peptide Technologies. Jan 5, 2006 663
Bioheart and Cleveland Clinic sign major patent licensing agreement. Jan 1, 2006 844
Affymetrix and Applied Biosystems Enter into Licensing Agreement. Dec 22, 2005 1137
Bio-tech firm sells off rights to product. Dec 9, 2005 335
Stem Cell Sciences KK signs agreement with the University of Nice to commercialize stem cell therapy for degenerative disease. Brief Article Nov 30, 2005 238
DiagnoCure signs license agreement with Genzyme for lung cancer associated genes. Nov 2, 2005 613
Clarient and Health Discovery Corporation announce bioinformatics patent licensing agreement. Nov 1, 2005 908
Nanogen issued patent for technology enabling assay development to detect difficult nucleic acid sequences. Nov 1, 2005 359
Meristem obtains United States patent. Brief Article Nov 1, 2005 97
CRYO-CELL Signs Exclusive License to Market New Stem Cell Service. Oct 17, 2005 1620
Genzyme signs licensing agreement with UCLA cancer center to develop CML markers. Oct 15, 2005 307
Agensys Signs Collaborative Research and License Agreement With sanofi pasteur. Oct 10, 2005 533
CRYO-CELL signs exclusive license to market new stem cell service. Company Profile Oct 1, 2005 1021
Stem Cell Therapy signs exclusive license agreement with Institute of Cell Therapy for supply of stem cells. Sep 30, 2005 257
InsectiGen enters licensing arrangement with Pioneer Hi-Bred. Aug 1, 2005 618
Agilent signals diagnostic plans for lab-on-a-chip. Brief Article Jul 15, 2005 161
Corautus announces collaboration and licensing agreement for treatment of diabetic neuropathy with VEGF-2. Jul 1, 2005 660
Lifebank Cryogenics, University of Alberta sign technology license agreement to pursue new clinical standard for stem cells. Brief Article May 23, 2005 223
CryoLife's cryopreserved orthopaedic tissues utilizing Clearant process implanted into human for first time. Brief Article May 13, 2005 140
Affymetrix licenses microfluidics technology from Caliper. Apr 1, 2005 546
Cimab, Chinese firm sign biotech deal. Brief Article Jan 1, 2005 226
Genelabs Technologies receives $1.25 Million from Affymetrix for amendment to non-exclusive license for DNA amplification technology. Dec 1, 2004 368
Affymetrix agreement gives Veridex non-exclusive rights to GeneChip technology. Dec 1, 2004 289
Roche renews internal research license for patented gene targeting technology from Lexicon. Brief Article Dec 1, 2004 253
Corgentech licenses peptide delivery system from Cyclacel. Sep 1, 2004 538
Bionomics licenses epilepsy test. Sep 1, 2004 696
Kereos and Dow sign licensing agreement for targeted imaging agents. Sep 1, 2004 558
AspenBio signs exclusive license with Washington University for reproductive patent estate. Jun 1, 2004 575
Peptimmune obtains exclusive license from Genzyme to develop and commercialize treatment for metabolic diseases including obesity. Jun 1, 2004 672
Juvaris Biotherapeutics announces licensing agreement for therapeutic vaccine platform. May 1, 2004 565
Peptimmune obtains exclusive license from Genzyme to develop and commercialize treatment for metabolic diseases including obesity. May 1, 2004 693
Geron grants XenoTrans license for nuclear transfer technology to produce transgenic pigs. Brief Article Apr 30, 2004 171
fqubed concludes technology licensing agreement with Pharmacopeia. Apr 1, 2004 619
Affymetrix announces expanded genomic technologies licensing program. Apr 1, 2004 425
DOV Pharmaceutical reorganizes indiplon license. Mar 1, 2004 490
Alnylam and Cenix enter into RNAi research service agreement. Feb 1, 2004 640
Adenoviral vector patent issued to University of Texas. Jan 1, 2004 382
Therion Biologics obtains rights to Biogen Idec LFA-3. Jan 1, 2004 389
Protiveris acquires license for Oak Ridge National Laboratory. Jan 1, 2004 417
Agenix and Biosite enter into license for D-dimer. Dec 1, 2003 600
Lexicon Genetics grants license to AstraZeneca. Dec 1, 2003 368
Human Genome Sciences licenses gene sequences to Pfizer. Brief Article Dec 1, 2003 103
diaDexus forms diagnostic license agreements with Human Genome Sciences. Brief Article Oct 1, 2003 218
Immune Response licenses Hybridon's AMPLIVAX vaccine adjuvant. Oct 1, 2003 656
Cambridge Antibody and Dyax amend antibody product agreement. Sep 1, 2003 552
Primagen and University of British Columbia enter mitochondrial DNA licensing agreement detection. Sep 1, 2003 365
EntreMed announces gene target delivery licensing deal with Oxford BioMedica. Sep 1, 2003 585
Amgen and Biovitrum sign metobolic disease license agreement. Sep 1, 2003 599
Genzyme Genetics licenses colon cancer diagnostic. Sep 1, 2003 572
Cambridge Antibody announces therapeutic antibody licence agreement with Micromet. Sep 1, 2003 555
United States company to sell nutraceutical cancer care business. Aug 1, 2003 799
Agenix secures diagnostic licenses from Abbott. Aug 1, 2003 355
454 Life Sciences obtains exclusive license from Pyrosequencing. Aug 1, 2003 908
ViaCell obtains worldwide exclusive license to patented oocyte cryopreservation technique. Aug 1, 2003 640
Human Genome Sciences licenses human gene technology to Genentech. Brief Article Aug 1, 2003 233
Human Genome Sciences acquires CCR5 receptor license from Abgenix. May 1, 2003 528
Introgen licenses fus1 gene from University of Texas. May 1, 2003 476
Introgen gains exclusive license to anti-cancer gene. Apr 1, 2003 476
Lexicon Genetics licenses patented gene targeting technology. Brief Article Apr 1, 2003 201
Angiotech broadens alliance with Baxter to include surgical sealant. Apr 1, 2003 297
Genetic Technologies grants non-coding license to Pathologists. Apr 1, 2003 325
Valentis licenses PEGylation technology. Feb 1, 2003 328
Valentis licenses PEGylation technology. Feb 1, 2003 328
Affymetrix hits $70 million clinical payday. (Executive briefing: news, trends & market intelligence for instrument executives). Brief Article Jan 31, 2003 174
Isis Pharmaceuticals enters into agreement with Pfizer. Jan 1, 2003 465
Ingenium licenses Incyte murine model patents. Jan 1, 2003 371
Isis license functional genomics patents to atugen. Jan 1, 2003 730
Cambridge Antibody and Dyax expand phage display license. Jan 1, 2003 391
Beckman Coulter buys orchid instrument business. (Executive briefing: news, trends & market intelligence for instrument executives). Brief Article Dec 31, 2002 171
SPIRE TRANSFERS HEMODIALYSIS CATHETER PATENT LICENSE TO BARD. Dec 1, 2002 306
Biotechnology. (Industry Watch). Brief Article Oct 15, 2002 164
Affymetrix signs gene expression agreement with Schering-Plough. Brief Article Oct 1, 2002 204
Medix licenses Immunomedics' carcinoembryonic antigen technology. Oct 1, 2002 449
Neurocrine and Taisho restructure diabetes agreement. Oct 1, 2002 424
BioStratum signs kidney disease treatment agreements with Genzyme. Brief Article Sep 1, 2002 552
Targeted Genetics expands patent portfolio for program. Brief Article Jun 1, 2002 589
Tanox enters licensing agreement for Its cancer gene. Brief Article Jun 1, 2002 330
Genetic Technologies licenses genomic mapping patents to Sequenom. Brief Article Apr 1, 2002 303
Advanced Cell announces license of its cloning. Brief Article Apr 1, 2002 388
Collateral Therapeutics acquires rights to the EPAS1 gene. Brief Article Mar 1, 2002 212
Ambion licenses RNA interference technology from MIT. Brief Article Mar 1, 2002 226
Cambridge Anitbody Technology gains access to Incyte cDNA clone database. Brief Article Dec 1, 2001 539
Millennium in-licenses novel oncology program from Xenova. Dec 1, 2001 1231
TriPath earns FDA nod for AutoCyte Prep system screening. (Industry Watch). Brief Article Dec 1, 2001 82
Hybridon Announces Early Receipt of $15 Million Payments Under Isis Cross-License Agreement. Nov 15, 2001 550
Maxygen and Aventis Pasteur Enter Strategic Alliance to Develop Improved Vaccines. Nov 5, 2001 721
Incyte Genomics Signs Exclusive Patent Agreement With Genentech to Enable Commercialization of Therapeutic Antibodies to Four Proteins. Oct 23, 2001 544
Incyte Genomics and Epoch Biosciences Enter Into License, Development And Supply Alliance. Oct 10, 2001 1004
Lexicon Genetics Licenses Patented Gene Targeting Technology to Pfizer Inc. Oct 10, 2001 385
Proteome Systems and Shimadzu Biotech Complete 1st Stage of The Chemical Printer Development. Oct 9, 2001 504
NetGenics DiscoveryCenter(TM) Selected by Paradigm Genetics. Oct 1, 2001 317
Integrative Proteomics and the University of Toronto Join Efforts to Map Bacterial Proteomes - Knowledge to Fight Infectious Disease. Oct 1, 2001 505
Tangerine and ImClone sign oligonucleotide license agreement. Brief Article Sep 1, 2001 353
Medigene expands exclusive license for the universal application of herpes simplex virus amplicon technology. Sep 1, 2001 440
Physiome Sciences Licenses PathwayPrism(TM) Biological Modeling Technology to 3rd Millennium for the Development of Models for Huntington's Disease. Aug 28, 2001 923
Demegen to Collaborate with Dow to Design New Compounds. Aug 27, 2001 521
Lexicon Genetics Licenses Patented Gene Targeting Technology To Merck & Co., Inc. Aug 23, 2001 347
Cell Genesys Licenses Lentiviral Gene Delivery Technology to Invitrogen For the Research Market. Aug 13, 2001 1271
Cell Genesys Licenses Lentiviral Gene Delivery Technology to Invitrogen For the Research Market. Aug 10, 2001 1271
Orchid and Affymetrix Expand Genotyping Licensing and Distribution Agreements - Orchid Adds Key Patent to Comprehensive Primer Extension Portfolio -. Aug 7, 2001 1363
Corvas International to License Incyte Genomics LifeSeq(R) Gold Database Online. Aug 1, 2001 1301
Valentis Licenses GeneSwitch(TM) Technology to Lexicon Genetics for Functional Genomics Research. Aug 1, 2001 609
Lexicon licenses patented gene targeting technology to Merck. Brief Article Aug 1, 2001 155
GeneMachines(R) Licenses Fundamental Microarray Fabrication Technology From Incyte Genomics, Inc. Jul 23, 2001 269
Lexicon Genetics Expands Collaboration With Oriental Yeast Company in Japanese Drug Discovery Market. Jul 10, 2001 731
Demegen Licenses Technology for Controlling Pierce's Disease. Jun 4, 2001 786
Physiome and University of Connecticut sign license for virtual cell technology. Brief Article Jun 1, 2001 477
Lifecodes to Develop HLA Applications on Luminex Technology. Apr 26, 2001 897
Millennium and BZL Biologics Announce Agreement To Develop Antibody Therapies Against Key Target In Prostate Cancer. Apr 11, 2001 1567
Eisai Co., Ltd. to License Incyte Genomics LifeSeq(R) Gold Online. Apr 9, 2001 700
MARKETING NEWS. Brief Article Apr 1, 2001 629
Gene Blues. THOMPSON, NICHOLAS Industry Overview Apr 1, 2001 3881
Merck licenses gene expression data microarray technology from Incyte. Brief Article Apr 1, 2001 258
NeoTherapeutics' NeoGene Signs License Agreement with Pfizer. Mar 19, 2001 555
Sangamo BioSciences Licenses Cell-Based Selection System From Massachusetts Institute of Technology and Harvard University. Mar 6, 2001 603
Millennium and ImmunoGen Form Multi-Product Antibody Collaboration. Mar 5, 2001 1083
Aslera(TM) New Drug Application to Be Reviewed at FDA Advisory Committee Meeting on April 19, 2001. Feb 20, 2001 725
Incyte Licenses Comprehensive Microarray Patent Portfolio to Chiron. Jan 11, 2001 419
BioMarin Exercises Option to Acquire Exclusive Rights to Proprietary Burn Product Candidate. Jan 11, 2001 947
Maxygen Announces Issuance of Additional Patents Covering Methods of Producing Chimeric Genes. Jan 9, 2001 504
Dyax Corp. and Human Genome Sciences Enter into Exclusive BLyS Purification License. Jan 8, 2001 625
Senomyx(SM), Inc. to License Incyte's Gene Sequence Databases For the Discovery of Genes Involved in Taste and Olfaction. Jan 5, 2001 787
Bionova Holding Completes Definitive Agreements With Savia and Wins Shareholder Lawsuit. Jan 5, 2001 1403
Affymetrix Grants Genomic Solutions a License to Commercialize Low and Medium Density DNA Arrays. Jan 4, 2001 741
Affymetrix and Lexicon Genetics sign Genechip Biotechaccess agreement. Brief Article Jan 1, 2001 194
Lexicon Genetics Grants Roche Bioscience Renewal to Technology Sublicense. Dec 19, 2000 381
Encore Pharmaceuticals Licenses Lead Cancer Compound to Myriad Genetics. Dec 8, 2000 583
Myriad Genetics Acquires Exclusive Rights to Cancer Drug In Phase II Human Clinical Trials. Dec 8, 2000 903
Sumitomo Pharmaceuticals to License LifeSeq Gold Online; Online Products Propel Penetration of Japanese Market. Dec 4, 2000 682
Genencor signs patent and know how license agreement with Protein Polymer Technologies. Brief Article Dec 1, 2000 428
Avigenics obtains rights to license Geron patents for generating cloned poultry. Brief Article Dec 1, 2000 325
Sankyo Co Ltd Becomes First Subscriber to LifeSeq Gold Online. Nov 30, 2000 712

Terms of use | Copyright © 2013 Farlex, Inc. | Feedback | For webmasters | Submit articles